NO986087L - Oral preparation comprising an antifungal triazole compound - Google Patents

Oral preparation comprising an antifungal triazole compound

Info

Publication number
NO986087L
NO986087L NO986087A NO986087A NO986087L NO 986087 L NO986087 L NO 986087L NO 986087 A NO986087 A NO 986087A NO 986087 A NO986087 A NO 986087A NO 986087 L NO986087 L NO 986087L
Authority
NO
Norway
Prior art keywords
beads
oral preparation
triazole compound
antifungal
triazol
Prior art date
Application number
NO986087A
Other languages
Norwegian (no)
Other versions
NO986087D0 (en
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO986087D0 publication Critical patent/NO986087D0/en
Publication of NO986087L publication Critical patent/NO986087L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

Et farmasøytisk preparat om-. fettende: i) hovedsakelig inerte per- ler; hvori angitte perler er belagt med ii) et antifungalt middel som er (-)- (2R-cis)-4-[4-[4-[4-[[-5-(2,4-difluor- fenyl)-tetrahydro-5-(1H-1,2,4-triazol- 1-ylmetyl)furan-3-yl]metoksy]fenyl]-1- piperazinyl]fenyl]-2,4-dihydro-2-[ (S)- l-etyl-2(S)-hydroksypropyl]-3H-1, 2,4- triazol-3-on; iii) et bindemiddel for å muliggjøre at den antifungale forbin- delse adhereres til angitte perler. Preparatet muliggjør at den antifungale forbindelse, som har meget lav vann- løselighet, får forøkt biotilgjengelig- het i pattedyr slik som mennesker.A pharmaceutical composition about. greasy: i) mainly inert beads; wherein said beads are coated with ii) an antifungal agent which is (-) - (2R-cis) -4- [4- [4- [4 - [[- 5- (2,4-difluorophenyl) tetrahydro] -5- (1H-1,2,4-triazol-1-ylmethyl) furan-3-yl] methoxy] phenyl] -1-piperazinyl] phenyl] -2,4-dihydro-2- [(S) -1 -ethyl-2 (S) -hydroxypropyl] -3H-1,2,4-triazol-3-one; iii) a binder to enable the antifungal compound to be adhered to specified beads. The preparation enables the antifungal compound, which has very low water solubility, to have increased bioavailability in mammals such as humans.

NO986087A 1996-06-28 1998-12-23 Oral preparation comprising an antifungal triazole compound NO986087L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28
PCT/US1997/010122 WO1998000116A1 (en) 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound

Publications (2)

Publication Number Publication Date
NO986087D0 NO986087D0 (en) 1998-12-23
NO986087L true NO986087L (en) 1999-02-26

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986087A NO986087L (en) 1996-06-28 1998-12-23 Oral preparation comprising an antifungal triazole compound

Country Status (16)

Country Link
EP (1) EP0914100A1 (en)
JP (1) JP2000514059A (en)
KR (1) KR20000022294A (en)
CN (1) CN1228693A (en)
AU (1) AU731704B2 (en)
BR (1) BR9710069A (en)
CA (1) CA2258683C (en)
CZ (1) CZ421498A3 (en)
HU (1) HUP9903869A3 (en)
IL (1) IL127780A0 (en)
NO (1) NO986087L (en)
NZ (1) NZ333514A (en)
PL (1) PL330864A1 (en)
SK (1) SK177598A3 (en)
TR (1) TR199802718T2 (en)
WO (1) WO1998000116A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129575A (en) * 1997-03-26 2004-06-20 Janssen Pharmaceutica Nv Pellets having a core coated with an antifungal and a polymer
JP2002517431A (en) * 1998-06-11 2002-06-18 イーエム インダストリーズ インコーポレイテッド Micro-osmotic pressure controlled drug delivery system
ID27549A (en) 1998-07-17 2001-04-12 Janssen Pharmaceutica Nv PELETS HAVE CORE COATED WITH ANTI MUSHROOMS AND A POLYMER
ES2157731B1 (en) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (en) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
KR100694667B1 (en) * 1999-12-08 2007-03-14 동아제약주식회사 Antifungal compositions containing itraconazole with both improved bioavailability and narrow intra- and inter-individual variation of its absorption
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
FR2842736B1 (en) 2002-07-26 2005-07-22 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S)
ITMI20031096A1 (en) * 2003-05-30 2004-11-30 Eurand Spa MICROCAPS FOR COACERVATION CONTAINING DRUG INCORPORATED IN THE COATING POLYMER
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN105949278B (en) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 Substituted tetrahydrofuran water-soluble derivative and application thereof
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
JP2834889B2 (en) * 1993-12-21 1998-12-14 シェーリング コーポレイション Tetrahydrofuran antifungal agent

Also Published As

Publication number Publication date
SK177598A3 (en) 1999-07-12
HUP9903869A3 (en) 2000-07-28
TR199802718T2 (en) 1999-03-22
JP2000514059A (en) 2000-10-24
CA2258683C (en) 2007-07-31
PL330864A1 (en) 1999-06-07
IL127780A0 (en) 1999-10-28
KR20000022294A (en) 2000-04-25
NZ333514A (en) 2000-05-26
BR9710069A (en) 1999-08-10
EP0914100A1 (en) 1999-05-12
CA2258683A1 (en) 1998-01-08
AU731704B2 (en) 2001-04-05
AU3387497A (en) 1998-01-21
HUP9903869A2 (en) 2000-06-28
CN1228693A (en) 1999-09-15
CZ421498A3 (en) 1999-06-16
WO1998000116A1 (en) 1998-01-08
NO986087D0 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
NO986087L (en) Oral preparation comprising an antifungal triazole compound
CO4970829A1 (en) ANTIFUNGAL CRYSTALLINE POLYMORPH
AR032279A1 (en) METHOD FOR INHIBITING ONE OR MORE ACTIVITIES OF PROTEINIC KINASE, COMPOSED OF 2 - PIRAZOLIN-5-ONA PROTEINIC QUINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
IE821285L (en) Triazole antifungal agents
KR920006323A (en) Azacyclic compounds
JP2001519346A5 (en)
ES8507541A1 (en) ((4-(4-(4-Phenyl-1-piperazinyl)phenoxymethyl)-1,3-dioxolan-2-yl)methyl)-1H-imidazoles and 1H-1,2,4-triazoles.
JP2002521400A5 (en)
CZ195696A3 (en) Azoles, process of their preparation and pharmaceutical compositions based thereon
AU2931399A (en) 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
NZ332699A (en) Antifungal composition with enhanced bioavailability
ES2223893T3 (en) COMBINATIONS OF FUNGICIDE ACTIVE PRODUCTS.
ES8707190A1 (en) Fungicidal alpha -(alkynylphenyl)azole ethanol compounds
RU97115290A (en) AZOL COMPOUNDS, METHOD FOR OBTAINING THE INDICATED COMPOUNDS AND THEIR APPLICATION
BRPI0610423B8 (en) ((2r, 3r)-3-(4-(4-cyanophenyl)-thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1h) dihydrogen phosphate mono-lysine salt -1,2,4-triazol-1-yl)butan-2-yloxy)methyl, solvates thereof, pharmaceutical composition comprising the same, use of said salt to treat fungal infections and processes for preparing said salt and sol- vato
RU97116580A (en) TRIAZOLE COMPOUND AND ITS PHARMACOLOGICALLY ACCEPTABLE SALT AND ANTI-FUNGAL COMPOSITION
BR0212536A (en) 3- (phenyl 2,6-disubstituted) -5- [4- or 5-arylthien-2- or -3-yl] -1,2,4-triazoles insecticide
DE60205239D1 (en) AZOL OR TRIAZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTIFUNGAL MEDICAMENTS
HUP9802763A2 (en) Phytomicrobicidal compositions and use thereof
EP1120397A3 (en) Process for preparing triazole derivative
ECSP982686A (en) ANTIFUNGAL CRYSTALLINE POLYFORM
ATE17478T1 (en) 3-SUBSTITUTED 1-AZOLYL-3-METHYL-1-PHENOXY-BUTANE-2-ONES AND -OLS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES.
UY25921A1 (en) ANTIMYCHOTIC AGENTS DERIVED FROM 1,2,4-TRIAZOLE AND COMPOSITIONS.-
WO2004108114B1 (en) Anti-fungal composition and a process for its manufacture
ECSP972133A (en) ANTI-FUNGAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application